P3 Health Partners is 1.8x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $1.65 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PIII | WGS |
|---|---|---|
| Market cap | $2.96 B | $1.65 B |
| US-listed rank | #1816 | #2251 |
| Revenue (latest FY) | $1.46B | $427.54M |
| Net income (latest FY) | -$147.95M | -$21.00M |
| Net margin | -10.1% | -4.9% |
| SEC filings | 387 | 748 |
P3 Health Partners is 1.8x more valuable than GeneDx Holdings Corp. by market capitalization ($2.96 B vs $1.65 B).
In their latest fiscal years, P3 Health Partners reported $1.46B in revenue while GeneDx Holdings Corp. reported $427.54M.
Full pages: P3 Health Partners and GeneDx Holdings Corp., or browse the full rankings.